These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24228980)

  • 1. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
    Gustafsson JT; Svenungsson E
    Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
    Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients].
    He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1910-3. PubMed ID: 22126778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in systemic lupus erythematosus: an update.
    Liu Y; Kaplan MJ
    Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.
    Bultink IE
    Arthritis Res Ther; 2010; 12(1):107. PubMed ID: 20236499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in Systemic Lupus Erythematosus.
    Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
    Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity, oxidized LDL and cardiovascular disease.
    Frostegård J
    Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
    Cederholm A; Frostegård J
    Immunobiology; 2005; 210(10):761-8. PubMed ID: 16325495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.